The use of oral contraceptives (OC) is a well established risk factor for venous thrombosis. It
has been known for many years that almost all haemostatic parameters ie plasma levels of …

Clinicians, including hematologists, are more frequently encountering transgender
individuals in practice; however, most lack training on the management and complications of …

Objectives To compare the effects of a combined oral contraceptive (COC) containing
nomegestrol acetate and 17β-oestradiol (NOMAC/E2) on haemostasis, lipids, carbohydrate …

Heightened publicity about hormonal contraception and thrombosis risk and the publication
of new guidelines by the World Health Organization in 2009 and the Centers for Disease …

Introduction: Venous thromboembolism (VTE) is a potential risk of estrogen therapy.
However, data show an improvement in the quality of life for transgender people who use …

Due to advances in caring for critically ill children and those with chronic diseases, rates of
deep vein thrombosis (DVT) are increasing in children. Risk factors consist of central venous …

A venous thromboembolism (VTE) event occurred in a female astronaut during long-
duration spaceflight. Multiple factors may have contributed to this risk, including the use of …

La contracepción hormonal es el método más utilizado para la prevención de los
embarazos no planificados. La literatura ha venido demostrando la asociación que existe …

OBJECTIVE: To compare the effect of ethinyl estradiol 20 μg/drospirenone 3 mg (EE 20
μg/DRSP 3 mg) administered according to a 24/4 regimen with ethinyl estradiol 20 …

Thrombosis is one of the major global causes of morbidity and mortality, and predicting the
risk of thrombotic and cardiovascular complications remains one of the key challenges in …